日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A High-Fiber, Plant-Based Diet in Myeloma Precursor Disorders: Results from the NUTRIVENTION Clinical Trial and Preclinical Vk*MYC Model

高纤维植物性饮食对骨髓瘤前驱疾病的影响:来自 NUTRIVENTION 临床试验和临床前 Vk*MYC 模型的结果

Shah, Urvi A; Cogrossi, Laura Lucia; Garcés, Juan-Jose; Policastro, Anna; Castro, Francesca; Derkach, Andriy; Fei, Teng; DeWolf, Susan; Grioni, Matteo; Sisti, Sofia; Blaslov, Jenna; Adintori, Peter A; Hosszu, Kinga K; McAvoy, Devin; Baichoo, Mirae; Cross, Justin R; Paredes, Jenny; Anuraj, Aishwarya; Raj, Sandeep S; Pohl, Charlotte; Zordan, Paola; Zinsmeyer, Victoria; Jesus Faustino Ramos, Ruben J; Lorenzoni, Marco; Gipson, Brianna; Maclachlan, Kylee H; Gradissimo, Ana; Boiocchi, Leonardo; Aleynick, Nathan; Marchigiani, Camilla; Pagani, Sara; Salehi, Erica; Koche, Richard P; Chaligne, Ronan; Block, Torin; Korde, Neha; Tan, Carlyn R; Hultcrantz, Malin; Hassoun, Hani; Shah, Gunjan L; Scordo, Michael; Lahoud, Oscar B; Chung, David J; Landau, Heather J; Peled, Jonathan U; Clementi, Nicola; Chesi, Marta; Bergsagel, P Leif; Mailankody, Sham; Pollak, Michael N; D'Souza, Anita; Landgren, Ola; Chimonas, Susan; Giralt, Sergio A; Usmani, Saad Z; Iyengar, Neil M; Lesokhin, Alexander M; van den Brink, Marcel R M; Bellone, Matteo

Dietary patterns among individuals with plasma cell disorders- opportunities for targeted interventions

浆细胞疾病患者的饮食模式——针对性干预的机会

Traore, Kadiatou; Castro, Francesca; Derkach, Andriy; Gorshein, Elan; Serrano, Edith; Taneja, Alankrita; Hurtado Martínez, Jorge Arturo; Lesokhin, Alexander M; Sahagun Sanchez Aldana, Ana M; Flores Pérez, Patricia Alejandra; Usmani, Saad Z; Ahlstrom, Jenifer M; Block, Torin; Hydren, Jay R; Thomson, Cynthia A; Shah, Urvi A

Racial differences in the proportion of myeloma cases attributable to excess body weight and diabetes mellitus in the United States

美国因超重和糖尿病导致的多发性骨髓瘤病例比例存在种族差异

Anuraj, Aishwarya; Rath, Divya; Derkach, Andriy; Usmani, Saad Z; Shah, Urvi A

Comparative Effectiveness and Safety of PI-Rd Triplets in Relapsed/Refractory Multiple Myeloma: INSIGHT-MM Data Analysis

PI-Rd三联疗法在复发/难治性多发性骨髓瘤中的疗效和安全性比较:INSIGHT-MM数据分析

Puig, Noemi; Leleu, Xavier; Lee, Hans C; Davies, Faith E; Hájek, Roman; Hungria, Vania; Thompson, Michael A; Cook, Gordon; Ojeda, Jorge Vela; Weisel, Katja C; Berdeja, Jesus G; Usmani, Saad Z; Symeonidis, Argiris; Nascimento-Ferreira, Isabel; Arthur, David; Mokrá, Lenka; Ren, Kaili; Cherepanov, Dasha; Terpos, Evangelos

CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in TP53

CD4+ T 细胞淋巴瘤携带嵌合抗原受体整合于 TP53

Perica, Karlo; Jain, Nayan; Scordo, Michael; Patel, Ruchi; Eren, Ozgur Can; Patel, Utsav; Gundem, Gunes; Domenico, Dylan; Mitra, Sneha; Socci, Nicholas D; Everett, John K; Roche, Aoife M; Petrichenko, Angelina; Shah, Gunjan L; Arcila, Maria E; Borsu, Laetitia; Park, Jae H; Horwitz, Steven M; Giralt, Sergio A; Dogan, Ahmet; Leslie, Christina; Papaemmanuil, Elli; Bushman, Frederic D; Usmani, Saad Z; Sadelain, Michel; Mailankody, Sham

Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma

在 CARTITUDE-1 研究中,接受 Ciltacabtagene Autoleucel 治疗的复发/难治性多发性骨髓瘤患者获得长期(≥5 年)缓解和生存。

Jagannath, Sundar; Martin, Thomas G; Lin, Yi; Cohen, Adam D; Raje, Noopur; Htut, Myo; Deol, Abhinav; Agha, Mounzer; Berdeja, Jesus G; Lesokhin, Alexander M; Liegel, Jessica J; Rossi, Adriana; Lieberman-Cribbin, Alex; Usmani, Saad Z; Dhakal, Binod; Parekh, Samir; Li, Hui; Wang, Feng; Montes de Oca, Rocio; Plaks, Vicki; Sun, Huabin; Banerjee, Arnob; Schecter, Jordan M; Lendvai, Nikoletta; Madduri, Deepu; Lengil, Tamar; Zhu, Jieqing; Koneru, Mythili; Akram, Muhammad; Patel, Nitin; Costa Filho, Octavio; Jakubowiak, Andrzej J; Voorhees, Peter M

Phase I Trial of MCARH109, a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma: An Updated Analysis

MCARH109(一种靶向G蛋白偶联受体C类5成员D (GPRC5D) 的嵌合抗原受体T细胞疗法)治疗多发性骨髓瘤的I期临床试验:最新分析

Jurgens, Eric M; Firestone, Ross S; Chaudhari, Jagrutiben; Hosszu, Kinga; Devlin, Sean M; Shah, Urvi A; Landa, Jonathan; McAvoy, Devin P; Lesokhin, Alexander M; Korde, Neha; Hassoun, Hani; Tan, Carlyn R; Hultcrantz, Malin; Shah, Gunjan L; Landau, Heather J; Chung, David J; Scordo, Michael; Eren, Ozgur Can; Dogan, Ahmet; Giralt, Sergio A; Park, Jae H; Rivière, Isabelle; Brentjens, Renier J; Smith, Eric L; Wang, Xiuyan; Usmani, Saad Z; Mailankody, Sham

Barriers to Chimeric Antigen Receptor T-Cell Therapy

嵌合抗原受体T细胞疗法的障碍

Valtis, Yannis K; Chin, Kuo-Kai; Nemirovsky, David; Devlin, Sean M; Yisraeli Salman, Meira; Boussi, Leora; Cadzin, Briana; McLoughlin, Carina; Cathcart, Elizabeth; Davis, Paul; Brooklyn, Chelsea; Goldstein, Todd; Famulare, Chris; Shah, Gunjan L; Walji, Moneeza; Scordo, Michael; Boardman, Alexander P; Shouval, Roni; Stein, Eytan M; Geyer, Mark B; Mailankody, Sham; Palomba, M Lia; Usmani, Saad Z; Salles, Gilles; Giralt, Sergio A; Perales, Miguel-Angel; Park, Jae H

Current and future role of carfilzomib-based quadruplet combinations as therapy for newly diagnosed multiple myeloma

卡非佐米四联疗法在治疗新诊断的多发性骨髓瘤中的当前和未来作用

Landgren, Ola; Biran, Noa; O'Donnell, Elizabeth K; Mikhael, Joseph; Weisel, Katja C; Broijl, Annemiek; Usmani, Saad Z; Moreau, Philippe; Gay, Francesca M; Mina, Roberto; Rodríguez-Otero, Paula; Jakubowiak, Andrzej J; Derman, Benjamin A

High WEE1 expression is independently linked to poor survival in multiple myeloma

WEE1高表达与多发性骨髓瘤患者预后不良独立相关。

Simhal, Anish K; Firestone, Ross S; Oh, Jung Hun; Avutu, Viswatej; Norton, Larry; Hultcrantz, Malin; Usmani, Saad Z; Maclachlan, Kylee H; Deasy, Joseph O